Long-term tamoxifen therapy: can an antagonist become an agonist?

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1996-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM.81.6.8964823PMID 8964823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid hormone receptors: many actors in search of a plot.

  1995cited by this paper
• Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells.

  1995cited by this paper
• Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

  1995cited by this paper
• Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

  1995cited by this paper
• Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

  1995cited by this paper
• Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

  1995cited by this paper
• When tamoxifen turns bad.

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

  1994cited by this paper
• New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent.

  1991cited by this paper
• Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

  1991cited by this paper
• Endocrine treatment of breast cancer in women.

  1990cited by this paper
• Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures

  1989cited by this paper
• Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.

  1989cited by this paper
• Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.

  1988cited by this paper

• Androgen-metabolizing enzymes: A structural perspective.

  2016cites this paper
• Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.

  2015cites this paper
• Inhibition of proliferation of estrogen receptor‑positive MCF‑7 human breast cancer cells by tamoxifen through c‑Jun transcription factors.

  2013cites this paper
• Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures

  2012cites this paper
• Dietary Flaxseed Interaction With Tamoxifen Induced Tumor Regression in Athymic Mice With MCF-7 Xenografts by Downregulating the Expression of Estrogen Related Gene Products and Signal Transduction Pathways

  2007cites this paper
• Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells

  2006cites this paper
• Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.

  2005cites this paper
• Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells.

  2005cites this paper
• Hormone replacement therapy in postmenopausal women.

  2004cites this paper
• [Use of tamoxifen in the treatment of Riedel's thyroiditis: report of a case].

  2004cites this paper
• Long-Term Exposure to Tamoxifen Induces Hypersensitivity to Estradiol

  2004cites this paper
• Uso do tamoxifeno no tratamento da tireoidite de Riedel: relato de um caso

  2004cites this paper
• New approaches to the understanding of tamoxifen action and resistance.

  2003cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention

  2003cites this paper
• Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor.

  2003cites this paper
• International Congress on Hormonal Steroids and Hormones and Cancer New approaches to the understanding of tamoxifen action and resistance

  2003cites this paper
• Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.

  2003influential citation
• Endocrine-Related Cancer ( 2003 ) 10 267 – 277 International Congress on Hormonal Steroids and Hormones and Cancer New approaches to the understanding of tamoxifen action and resistance

  2003cites this paper
• Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.

  2002cites this paper
• Letrozole for the management of breast cancer

  2002cites this paper
• A 60-year-old woman trying to discontinue hormone replacement therapy.

  2002cites this paper
• Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.

  2001cites this paper
• Tamoxifen Prevents Bone Loss in Castrated Male Mice

  2000cites this paper
• Coregulatory proteins in nuclear hormone receptor action.

  1999cites this paper
• An Estrogen Receptor Paradox: Why Do Estrogen and Tamoxifen Antagonize Each Other's Activity?

  1999cites this paper
• Use of aromatase inhibitors in breast carcinoma.

  1999influential citation
• Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.

  1997cites this paper
• Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.

  1997cites this paper
• Osteoporosis: new hope for the future.

  1997cites this paper
• The endocrinology of aging.

  1997cites this paper
• Effects of tamoxifen on GH and IGF-I levels in acromegaly

  1997cites this paper